Projected Price to Earnings: Apyx Medical Corporation (APYX)
Apyx Medical production capacities operate at maximum efficiency due to the automation of electronics control. The company's forward P/E demonstrates fundamental value potential, where 0.00 characterizes this valuation parameter. Business growth relies on the expansion of Renuvion technology within the B2B segment, although a high dependence on consumer optimism makes revenue sensitive to economic downturns.
Metric breakdowns and analytics for Bovie Medical (APYX)
- stock quotes and analyst forecast:
- company stock exchange capitalization indicators:
- issuer book value statistics:
- company liabilities and liquidity data:
Total Debt to Capital Apyx Medical|APYX - Long-Term Debt to Equity Ratio|Short-Term Debt to Equity Ratio Apyx Medical|APYX - Aggregate Debt Obligations|Debt to Book Capitalization Ratio Apyx Medical Corp|APYX - Company Long-Term Liabilities|Company Short-Term Debts Apyx Medical|Quick Ratio apyxmedical.com
- financial results and valuation multiples details:
APYX - Company Profit|Projected Future Earnings Apyx Medical|APYX - Business Payback Period|Forward P/E Multiple Apyx Medical|APYX - Price/Earnings to Growth Multiple|EV/EBITDA Multiple Apyx Medical Corp|APYX - Operating profit EBITDA|Earnings per share for the last twelve months Apyx Medical|APYX - Earnings per share for the last twelve months|Year-over-year net earnings per share growth for the last 12 months apyxmedical.com|APYX - Earnings per share increase in current year|Earnings growth forecast for next year Apyx Medical
Fundamental valuation:APYX Apyx Medical Corporation
Apyx Medical (APYX) monetizes the exclusivity of its Renuvion helium plasma technology through premium pricing and recurring sales of consumables. The ratio of market capitalization to projected forward earnings, reflected in the company's forward P/E, allows for an assessment of the asset's current fair value relative to expected income, helping investors timely identify whether the business is overbought or undervalued.
Competitors of Apyx Medical
Forward P/E Multiple DXCM|PEN - Projected Price to Earnings Ratio|Novanta Corp - Projected Price to Earnings|Forward P/E Multiple Haemonetics Company HAE|INSP: Projected Price to Earnings|procept-biorobotics.com - Market Cap to Future Earnings Ratio|CNMD: Forward P/E Multiple|PLSE - Market Cap to Projected Earnings|INMD (InMode Corp) - Forward P/E Multiple|Projected Price to Earnings Picard Group (PMI)|Projected Price to Earnings SRDX (Surmodics, Inc.)|SENS (Senseonics Holdings, Inc.) - Future Price to Earnings Multiple|Future Price to Earnings NeuroPace NPCE|TCMD - Projected Price to Earnings|SANUWAVE Health, Inc. - Forward P/E Multiple|Projected Price to Earnings Ratio Outset Medical Corp|ELMD: Forward P/E Multiple|Price to Future Earnings Ratio LNSR|RCEL (AVITA Medical) - Forward P/E Multiple|Profound Medical Corporation (PROF) - Market Cap to Projected Earnings|Forward P/E Multiple BDMD|Projected Price to Earnings edap-tms.com EDAP|Forward P/E Multiple ICCM (IceCure Medical)|Forward P/E Multiple Pulmonx Corp LUNG|TELA - Future Price to Earnings|CTSO: Future Price to Earnings|SRTS (Sensus Healthcare Corp) - Projected Price to Earnings|Zynex Corp - Future Price to Earnings Multiple|ECOR (electroCore Inc) - Forward P/E Multiple|Projected Price to Earnings Ratio Vicarious Surgical Corp RBOT|Future Price to Earnings Inspira Technologies Oxy (IINN)|SeaStar Medical Holding Corporation (ICU) - Forward Price to Earnings Multiple|IRIDEX - Projected Price to Earnings|Forward P/E Multiple Intelligent Bio Solutions Inc INBS|AINostix - Forward P/E Multiple|Market Cap to Projected Earnings profusa.com PFSA|strataskinsciences.com (SSKN) - Future Price to Earnings|Price to Expected Earnings Ratio GCTK (glucotrack.com)|Future Price to Earnings NanoVibronix|Projected Price to Earnings Venus Concept Corporation (VERO)|Forward P/E Multiple NUWE|AEMD - Projected Price to Earnings Ratio|Future Price to Earnings Asensus Surgical ASXC|AVGR: Price to Future Earnings Ratio|BSGM: Projected Price to Earnings|Cutera Inc - Market Cap to Future Earnings Ratio|KNW: Forward P/E Multiple|inarimedical.com (NARI) - Forward P/E Multiple|Future Price to Earnings Nevro|ReShape Lifesciences Inc - Price to Expected Earnings Ratio|Projected Price to Earnings SILK (Silk Road Medical Inc.)
